Risk Of Developing Liver Cancer After HCV Treatment

Sunday, October 4, 2015

Patients have mixed feelings about hepatitis drugs

Patients have mixed feelings about hepatitis drugs
By Vickie Aldous
Mail Tribune

Posted Oct. 4, 2015 at 12:01 AM

Patients who have coped for years with hepatitis C have had mixed reactions to new drugs that can cure the disease, from elation about the treatment to shock about the price.
The woman said the Sovaldi cost $85,000. Medicare and her supplemental insurance policy together covered $75,000 of the cost. Her doctor helped her get $10,500 from the Patient Access Network, a nonprofit organization dedicated to helping people with chronic or life-threatening diseases for whom costs limit access to critical treatments.

Continue reading... 

No comments:

Post a Comment